At a glance
- Originator Bristol-Myers Squibb
- Class Antihypertensives; Imidazoles; Sulfonamides
- Mechanism of Action Angiotensin type 1 receptor antagonists; Angiotensin type 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 16 Nov 1998 No-Development-Reported for Hypertension in USA (Unknown route)
- 10 May 1996 A radioligand binding study has been added to the pharmacodynamics section